BioCardia, Inc. Annual Costs and Expenses in USD from 2015 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
BioCardia, Inc. quarterly/annual Costs and Expenses history and growth rate from 2015 to 2023.
  • BioCardia, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $1.76M, a 40.6% decline year-over-year.
  • BioCardia, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $7.84M, a 40.4% decline year-over-year.
  • BioCardia, Inc. annual Costs and Expenses for 2023 was $12.1M, a 8.54% decline from 2022.
  • BioCardia, Inc. annual Costs and Expenses for 2022 was $13.3M, a 2.87% decline from 2021.
  • BioCardia, Inc. annual Costs and Expenses for 2021 was $13.6M, a 12.9% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $12.1M -$1.13M -8.54% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-27
2022 $13.3M -$392K -2.87% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-27
2021 $13.6M -$2.03M -12.9% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-29
2020 $15.7M +$751K +5.03% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-29
2019 $14.9M +$196K +1.33% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-30
2018 $14.7M +$1.84M +14.3% Jan 1, 2018 Dec 31, 2018 10-K 2020-04-09
2017 $12.9M +$4.7M +57.4% Jan 1, 2017 Dec 31, 2017 10-K 2020-04-09
2016 $8.18M +$1.87M +29.6% Jan 1, 2016 Dec 31, 2016 10-K 2019-04-02
2015 $6.31M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.